Bernard Michael Hennessy
Hoffmann-La Roche
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Bernard Michael Hennessy.
Tetrahedron | 1984
Peter Michael Wovkulich; F. Barcelos; Andrew D. Batcho; John Sereno; Enrico G. Baggiolini; Bernard Michael Hennessy; Milan R. Uskokovic
A total synthesis of 1α,25S,26-trihydroxycholecalciferol (2) has been accomplished via an efficient convergent approach. The remote chiral center at C-25 was introduced by a regiospecific and diastereoselective 1,3-dipolar cycloaddition of the C-23 nitrone 27 with methyl methacrylate. Subsequent transformation of the resulting isoxazolidine led to the key synthon 3, which on coupling to the anion 4 and deprotection produced the metabolite 2.
Tetrahedron Letters | 1987
Enrico G. Baggiolini; Bernard Michael Hennessy; Jerome Anthony Iacobelli; Milan R. Uskokovic
Abstract The dihydroxyaldehyde 1 , an important intermediate for the synthesis of 1α-hydroxylated vitamin D derivatives via the corresponding tachysterol precursors, was prepared from (S)-(+)-carvone ( 6 ). The sequence involves as central step, the decarboxylation and rearrangement of the epoxyglycidic acid 15 , prepared from carvone oxide 7 .
Bioorganic & Medicinal Chemistry Letters | 2008
Shawn David Erickson; Bruce L. Banner; Steven Joseph Berthel; Karin Conde-Knape; Fiorenza Falcioni; Irina Hakimi; Bernard Michael Hennessy; Robert Francis Kester; Kyungjin Kim; Chun Ma; Warren William Mccomas; Francis A. Mennona; Steven Gregory Mischke; Lucy Orzechowski; Yimin Qian; Hamid Salari; John P. Tengi; Kshitij Chhabilbhai Thakkar; Rebecca Taub; Jefferson Wright Tilley; Hong Wang
This paper describes the lead optimization of a new series of potent, selective, orally bioavailable, brain-penetrant MCH-1 receptor antagonists. A major focus of the work was to achieve a selectivity profile appropriate for in vivo efficacy studies and safety.
Bioorganic & Medicinal Chemistry | 1998
Marek M. Kabat; Walter Burger; Sandra E. Guggino; Bernard Michael Hennessy; Jerome Anthony Iacobelli; Kazuhiro Takeuchi; Milan R. Uskokovic
Separation of genomic and nongenomic vitamin D activities was achieved by structural modification of 1,25-dihydroxy vitamin D3 by introduction of 16 and 23E double bonds. The modified compound 3, lacking a 1 alpha-hydroxy group, exhibits only nongenomic activity. Its 1 alpha-hydroxy relative 4 expresses fully both genomic and non-genomic activities. A total synthesis of analogues 3 and 4 is described.
Heterocycles | 1993
Peter Michael Wovkulich; Enrico G. Baggiolini; Bernard Michael Hennessy; Milan R. Uskokovic
The intramolecular dipolar cycloadditions of nitrones derived from aldehydes (8) and (14) were found to proceed with a high degree of diastereoselectivity. By taking advantage of the functionality and stereochemical features residing in the cycloadducts (10) and (11), respectively, the two novel vitamin D 2 derivatives (1c) and (1d) were synthesized
Bioorganic & Medicinal Chemistry Letters | 1993
Andrew D. Batcho; John Sereno; Bernard Michael Hennessy; Enrico G. Baggiolini; Milan R. Uskokovic; Ronald L. Horst
Abstract A convergent total synthesis of 1α,25,28-trihydroxyergocalciferol (1), using an available A ring synthon and a CD synthon which was prepared via a thermodynamically controlled dipolar cycloaddition of methyl 3,3-dimethylacrylate and a C-23 nitrone followed by subsequent removal of the nitrogen function, is described.
Journal of Organic Chemistry | 1986
Enrico G. Baggiolini; Jerome Anthony Iacobelli; Bernard Michael Hennessy; Andrew D. Batcho; John Sereno; Milan R. Uskokovic
Archive | 2000
Andrew D. Batcho; Bernard Michael Hennessy; Milan R. Uskokovic
Journal of the American Chemical Society | 1982
Enrico G. Baggiolini; Jerome Anthony Iacobelli; Bernard Michael Hennessy; Milan R. Uskokovic
Archive | 1993
Thomas I. Doran; Bernard Michael Hennessy; John A. McLane; Giacomo Pizzolato; Farhad Sedarati; Milan R. Uskokovic